Amplia Therapeutics Limited (ATX.AX)
AUD 0.05
(1.92%)
AUD 0.05
(1.92%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 3.42 Million AUD | 20.29% |
| 2023 | 2.84 Million AUD | 8.07% |
| 2022 | 2.63 Million AUD | 388.95% |
| 2021 | 539.13 Thousand AUD | 5.58% |
| 2020 | 510.62 Thousand AUD | -3.08% |
| 2019 | 526.85 Thousand AUD | 88.55% |
| 2018 | 279.42 Thousand AUD | -69.22% |
| 2017 | 907.87 Thousand AUD | -11.97% |
| 2016 | 1.03 Million AUD | 127.72% |
| 2015 | 452.89 Thousand AUD | 12.18% |
| 2014 | 403.73 Thousand AUD | 111.38% |
| 2013 | 191 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 3.42 Million AUD | 20.29% |
| 2024 Q2 | 2.8 Million AUD | 0.0% |
| 2024 Q4 | 3.42 Million AUD | 0.0% |
| 2023 Q4 | 2.84 Million AUD | 0.0% |
| 2023 Q2 | 2.79 Million AUD | 0.0% |
| 2023 FY | 2.84 Million AUD | 8.07% |
| 2022 FY | 2.63 Million AUD | 388.95% |
| 2022 Q2 | 336.42 Thousand AUD | 0.0% |
| 2022 Q4 | 2.63 Million AUD | 0.0% |
| 2021 Q4 | 539.13 Thousand AUD | 0.0% |
| 2021 Q2 | 615.55 Thousand AUD | 0.0% |
| 2021 FY | 539.13 Thousand AUD | 5.58% |
| 2020 Q4 | 510.62 Thousand AUD | 0.0% |
| 2020 Q2 | 218.19 Thousand AUD | 0.0% |
| 2020 FY | 510.62 Thousand AUD | -3.08% |
| 2019 Q2 | 195.25 Thousand AUD | 0.0% |
| 2019 Q4 | 526.85 Thousand AUD | 0.0% |
| 2019 FY | 526.85 Thousand AUD | 88.55% |
| 2018 Q4 | 279.42 Thousand AUD | 0.0% |
| 2018 FY | 279.42 Thousand AUD | -69.22% |
| 2018 Q2 | 545.68 Thousand AUD | 0.0% |
| 2017 Q2 | 1.02 Million AUD | 0.0% |
| 2017 FY | 907.87 Thousand AUD | -11.97% |
| 2017 Q4 | 907.87 Thousand AUD | 0.0% |
| 2016 Q2 | 507.49 Thousand AUD | 0.0% |
| 2016 Q4 | 1.03 Million AUD | 0.0% |
| 2016 FY | 1.03 Million AUD | 127.72% |
| 2015 Q3 | 452.89 Thousand AUD | 35.8% |
| 2015 Q2 | 333.51 Thousand AUD | 0.0% |
| 2015 Q1 | 333.51 Thousand AUD | 0.0% |
| 2015 FY | 452.89 Thousand AUD | 12.18% |
| 2015 Q4 | 452.89 Thousand AUD | 0.0% |
| 2014 Q1 | 5.11 Million AUD | 0.0% |
| 2014 FY | 403.73 Thousand AUD | 111.38% |
| 2013 FY | 191 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AdAlta Limited | 3.54 Million AUD | 3.268% |
| Acrux Limited | 5.68 Million AUD | 39.743% |
| Actinogen Medical Limited | 1.61 Million AUD | -112.137% |
| AnteoTech Limited | 4.07 Million AUD | 15.912% |
| Argenica Therapeutics Limited | 2.42 Million AUD | -41.211% |
| Arovella Therapeutics Limited | 2.05 Million AUD | -66.622% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -1016.77% |
| Alterity Therapeutics Limited | 5.42 Million AUD | 36.841% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -263.957% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -830.068% |
| Biome Australia Limited | 5.37 Million AUD | 36.225% |
| Biotron Limited | 737.5 Thousand AUD | -364.646% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | 8.18% |
| BTC Health Limited | 203.94 Thousand AUD | -1580.232% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | 73.235% |
| CSL Limited | 27.88 Billion AUD | 99.988% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | 58.871% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 87.81% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -192.625% |
| Dimerix Limited | 13.89 Million AUD | 75.334% |
| EZZ Life Science Holdings Limited | 4.22 Million AUD | 18.972% |
| Hexima Limited | 248.67 Thousand AUD | -1278.051% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -227.728% |
| Immuron Limited | 2.84 Million AUD | -20.64% |
| Immutep Limited | 10.97 Million AUD | 68.789% |
| Imugene Limited | 33.14 Million AUD | 89.661% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -693.92% |
| Memphasys Limited | 5.59 Million AUD | 38.724% |
| Nanollose Limited | 465.64 Thousand AUD | -635.928% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 91.987% |
| Noxopharm Limited | 1.28 Million AUD | -165.929% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -3899.392% |
| Nyrada Inc. | 855.63 Thousand AUD | -300.499% |
| Orthocell Limited | 22.08 Million AUD | 84.482% |
| PharmAust Limited | 896.6 Thousand AUD | -282.196% |
| Patrys Limited | 691.36 Thousand AUD | -395.657% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | 4.395% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | -110.76% |
| Prescient Therapeutics Limited | 2.32 Million AUD | -47.354% |
| PYC Therapeutics Limited | 10.18 Million AUD | 66.351% |
| Race Oncology Limited | 1.91 Million AUD | -78.812% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 92.331% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 78.439% |
| Starpharma Holdings Limited | 8.69 Million AUD | 60.602% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 98.626% |
| Tissue Repair Ltd | 1.35 Million AUD | -153.667% |
| Zelira Therapeutics Limited | 9.35 Million AUD | 63.376% |